Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDVeradermics Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.64 | -$0.64 | -$0.64 |
| Q2 2026 | 3 | -$0.65 | -$0.65 | -$0.65 |
| Q3 2026 | 3 | -$0.61 | -$0.61 | -$0.61 |
| Q4 2026 | 3 | -$0.63 | -$0.63 | -$0.63 |
| Q1 2027 | 1 | -$0.53 | -$0.53 | -$0.53 |
| Q2 2027 | 1 | -$0.60 | -$0.60 | -$0.60 |
| Q3 2027 | 1 | -$0.66 | -$0.66 | -$0.66 |
| Q4 2027 | 1 | -$0.89 | -$0.89 | -$0.89 |
Veradermics Inc Earnings Date And Information
Veradermics Inc last posted its earnings results on Tuesday, August 11th, 2026. The company reported $-0.58 earnings per share for the quarter, topping analysts' consensus estimates of $-0.64756 by $0.06756. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Veradermics Inc has generated $-2 earnings per share over the last year ($-2.38 diluted earnings per share) and currently has a price-to-earnings ratio of -52.71. Veradermics Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Veradermics Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 06/30/2026 | Q2 2026 | N/A | -$0.58 | N/A | $0 | $0 |
| 03/30/2026 | Q1 2026 | N/A | -$0.80 | N/A | $0 | $0 |
| 12/31/2025 | Q4 2025 | N/A | -$0.76 | N/A | $0 | $0 |
| 09/30/2025 | Q3 2025 | N/A | $0.00 | N/A | N/A | $0 |
| 12/31/2024 | Q4 2024 | N/A | -$0.03 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Veradermics Inc Earnings: FAQ's
In the previous quarter, Veradermics Inc (:MANE) reported $-0.58 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.64756 by $0.06756.
The conference call for Veradermics Inc's latest earnings report can be listened to online.
The conference call transcript for Veradermics Inc's latest earnings report can be read online.
Veradermics Inc (:MANE) has a recorded net income of $-69,995,000.Veradermics Inc has generated $-2.38 earnings per share over the last four quarters.
Veradermics Inc (:MANE) has a price-to-earnings ratio of -52.71 and price/earnings-to-growth ratio is 1.84.